ZA939576B - P-(bis(2-chloroethyl) amino)phenylalanine compounds process for preparing them and pharmaceutical compositions containing them - Google Patents
P-(bis(2-chloroethyl) amino)phenylalanine compounds process for preparing them and pharmaceutical compositions containing themInfo
- Publication number
- ZA939576B ZA939576B ZA939576A ZA939576A ZA939576B ZA 939576 B ZA939576 B ZA 939576B ZA 939576 A ZA939576 A ZA 939576A ZA 939576 A ZA939576 A ZA 939576A ZA 939576 B ZA939576 B ZA 939576B
- Authority
- ZA
- South Africa
- Prior art keywords
- chloroethyl
- bis
- amino
- preparing
- pharmaceutical compositions
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000002993 phenylalanine derivatives Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9215319A FR2699536B1 (fr) | 1992-12-21 | 1992-12-21 | Nouveaux dérivés de p-[di(2-chloroéthyl)amino]phénylalanine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA939576B true ZA939576B (en) | 1994-08-11 |
Family
ID=9436794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA939576A ZA939576B (en) | 1992-12-21 | 1993-12-21 | P-(bis(2-chloroethyl) amino)phenylalanine compounds process for preparing them and pharmaceutical compositions containing them |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5424464A (xx) |
| EP (1) | EP0604301B1 (xx) |
| JP (1) | JPH06247914A (xx) |
| AT (1) | ATE138641T1 (xx) |
| AU (1) | AU661622B2 (xx) |
| CA (1) | CA2111875A1 (xx) |
| DE (1) | DE69302889T2 (xx) |
| DK (1) | DK0604301T3 (xx) |
| ES (1) | ES2089761T3 (xx) |
| FR (1) | FR2699536B1 (xx) |
| GR (1) | GR3020323T3 (xx) |
| NZ (1) | NZ250512A (xx) |
| ZA (1) | ZA939576B (xx) |
-
1992
- 1992-12-21 FR FR9215319A patent/FR2699536B1/fr not_active Expired - Fee Related
-
1993
- 1993-12-17 AU AU52510/93A patent/AU661622B2/en not_active Ceased
- 1993-12-20 NZ NZ250512A patent/NZ250512A/en unknown
- 1993-12-20 JP JP5320372A patent/JPH06247914A/ja active Pending
- 1993-12-20 CA CA002111875A patent/CA2111875A1/fr not_active Abandoned
- 1993-12-20 US US08/170,055 patent/US5424464A/en not_active Expired - Fee Related
- 1993-12-21 AT AT93403109T patent/ATE138641T1/de not_active IP Right Cessation
- 1993-12-21 ZA ZA939576A patent/ZA939576B/xx unknown
- 1993-12-21 ES ES93403109T patent/ES2089761T3/es not_active Expired - Lifetime
- 1993-12-21 DK DK93403109.7T patent/DK0604301T3/da active
- 1993-12-21 EP EP93403109A patent/EP0604301B1/fr not_active Expired - Lifetime
- 1993-12-21 DE DE69302889T patent/DE69302889T2/de not_active Expired - Fee Related
-
1996
- 1996-06-24 GR GR960401692T patent/GR3020323T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3020323T3 (en) | 1996-09-30 |
| EP0604301B1 (fr) | 1996-05-29 |
| AU5251093A (en) | 1994-06-30 |
| FR2699536B1 (fr) | 1995-03-03 |
| DK0604301T3 (da) | 1996-10-14 |
| NZ250512A (en) | 1995-03-28 |
| DE69302889T2 (de) | 1996-11-28 |
| FR2699536A1 (fr) | 1994-06-24 |
| DE69302889D1 (de) | 1996-07-04 |
| EP0604301A1 (fr) | 1994-06-29 |
| ATE138641T1 (de) | 1996-06-15 |
| AU661622B2 (en) | 1995-07-27 |
| JPH06247914A (ja) | 1994-09-06 |
| ES2089761T3 (es) | 1996-10-01 |
| CA2111875A1 (fr) | 1994-06-22 |
| US5424464A (en) | 1995-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA913772B (en) | Aminopiperidine,aminopyrrolidine and aminoperhydrozapine compounds,processes for the preparation thereof and pharmaceutical compositions containing them | |
| ZA932168B (en) | Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them | |
| YU49175B (sh) | Postupak za dobijanje derivata bakatina iii i 10-dezacetil-bakatina iii | |
| IL110151A0 (en) | Amide and urea derivatives and pharmaceutical compositions containing the same | |
| IL101839A0 (en) | Peptide compounds,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
| IE893653L (en) | Compositions and compounds | |
| AU6052494A (en) | 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them | |
| EP0529452A3 (de) | 1,7-anellierte 2-(Piperazino-alkyl)indol-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| ZA945337B (en) | Benzospiroalkene compounds process for preparing them and pharmaceutical compositions containing them | |
| ZA932359B (en) | 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them | |
| ZA912618B (en) | 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them | |
| CA2137889A1 (fr) | Nouveaux analogues de l'eburnane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ZA939576B (en) | P-(bis(2-chloroethyl) amino)phenylalanine compounds process for preparing them and pharmaceutical compositions containing them | |
| ZA945336B (en) | Benzospiroalkene compounds process for preparing them and pharmaceutical compositions containing them | |
| DK0578521T3 (da) | Hidtil ukendt peptid-derivater med bradykininantagonistisk virkning, fremgangsmåde til fremstilling af derivaterne og farmaceutiske sammensætninger indeholdende disse | |
| EP0321273A3 (en) | Thioformamide derivatives | |
| ZA911524B (en) | Derivatives of pyridylsulfonylurea and of pyridylsulfonyl-thiourea,process for preparing these and pharmaceutical compositions containing them | |
| ZA945331B (en) | Benzospiroalkene compounds process for preparing them and pharmaceutical compositions containing them | |
| AU1234588A (en) | New acetamides derived from 2,3-dihydro-3-phenyl-2-benzofuranone, processes for preparing them and the pharmaceutical compositions which contain them |